Sachin Sanap | Pharmacology | Best Researcher Award

Published on by Life Science

Dr. Sachin Sanap | Pharmacology | Best Researcher Award

Sun Pharmaceutical Industries Limited | India

Dr. Sachin N. Sanap, Ph.D., is an accomplished Formulation Scientist with over five years of research and development experience spanning academia and the pharmaceutical industry. His expertise lies in parenteral drug formulation, lyophilization, and regulatory-compliant product development, with a strong focus on improving drug delivery efficiency and stability. Dr. Sanap has made significant scientific contributions, authoring 30 research articles, 16 review papers, one book chapter, and securing one patent. His impactful work has earned him an h-index of 15, i10-index of 27, and over 1,200 citations, reflecting his influence in pharmaceutical formulation science. A recipient of the prestigious AcSIR Best PhD Thesis Award  and multiple honors including the Sun Pharma Spotlight Award, Dr. Sanap’s research emphasizes innovative approaches to ophthalmic, peptide, and injectable formulations. His projects, such as sustained-release ophthalmic systems and polymeric liposomal formulations for keratitis, demonstrate translational relevance in therapeutics. Through interdisciplinary collaborations, he bridges laboratory innovation with industrial application, contributing to Cipla–CDRI technology transfer initiatives. With a passion for advancing drug delivery systems, Dr. Sanap continues to explore scalable, bioavailable, and patient-centered pharmaceutical solutions for global healthcare challenges.

Profiles: Google Scholar | Research Gate | LinkedIn

Featured Publications

Biswas, A., Choudhury, A. D., Agrawal, S., Bisen, A. C., Sanap, S. N., Verma, S. K., & others. Recent insights into the etiopathogenesis of diabetic retinopathy and its management. Journal of Ocular Pharmacology and Therapeutics, 40(1), 13–33.

Sanap, S. N., Bisen, A. C., Kedar, A., Yadav, K. S., Krishna, A., Akhir, A., Chopra, S., & others. Chitosan/HPMC-based mucoadhesive film co-loaded with fluconazole and ofloxacin for management of polymicrobial keratitis. International Journal of Biological Macromolecules, 222, 2785–2795.

Sanap, S. N., Bisen, A. C., Mishra, A., Biswas, A., Agrawal, S., Yadav, K. S., & others. QbD based antifungal drug-loaded ophthalmic liposomal formulation for the management of fungal keratitis: In vitro, ex vivo and in vivo pharmacokinetic studies. Journal of Drug Delivery Science and Technology, 74, 103517.

Sanap, S. N., Mishra, A., Bisen, A. C., Agrawal, S., Biswas, A., Verma, S. K., & others.  Simultaneous determination of fluconazole and ofloxacin in rabbit tear fluid by LC-MS/MS: Application to ocular pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis, 208, 114463.

Mishra, A., Bano, M., Bisen, A. C., Verma, S., Sanap, S. N., Kishor, R., Shukla, P. K., & others. Topical corneal targeted sustained release amphotericin B liposomal formulation for the treatment of fungal keratitis and its PK–PD evaluation. Journal of Drug Delivery Science and Technology, 60, 101944.

.

Soumia Belouafa | Pharmacology | Best Researcher Award

Published on by Life Science

Prof. Soumia Belouafa | Pharmacology | Best Researcher Award

Faculty Ben M’Sick. University Hassan II Casablanca | Morocco

Prof. Soumia Belouafa, a distinguished Professor of Chemistry at the Faculty of Ben M’Sick, Hassan II University of Casablanca, Morocco, has made notable contributions in the field of biomaterials, materials chemistry, and process engineering. Her research primarily focuses on the controlled synthesis of calcium phosphate biomaterials and the application of Quality-by-Design (QbD) methodologies for reproducible and scalable production. With an impressive portfolio of 26 Scopus-indexed journal publications and 10 additional papers, her scholarly influence is reflected in an h-index of 7 and 188 citation counts across leading research platforms such as Scopus and ResearchGate. Prof. Belouafa has successfully integrated process optimization and statistical control in pilot-scale biomaterial synthesis, enhancing reproducibility and clinical applicability for bone regeneration. Her innovative research extends to sustainable material development, including the valorization of marine by-products and eco-efficient antibacterial dental biomaterials. In addition to her academic publications, she holds three patents, evidencing her commitment to translating laboratory innovations into industrial and environmental applications. Through her interdisciplinary approach combining chemistry, process engineering, and analytical validation, Prof. Belouafa has strengthened the bridge between academic science and industrial biotechnology, positioning herself as a leading figure in advanced biomaterials research and innovation.

Profiles: Scupos | Orcid | Google Scholar 

Featured Publications

Outalb, K., Chaair, H., Digua, K., & Belouafa, S. (2026). Temperature control in an ultrasonic bath: A statistical experimental approach. Journal of Thermal Engineering.

Belouafa, S., Berrada, M., Digua, K., & Chaair, H. (2026, July). Design and scale-up of a synthesis process for antimicrobial oxygenated apatites for biomedical applications. Johnson Matthey Technology Review.

Belouafa, S., Berrada, M., Digua, K., & Chaair, H. (2025, June 30). Kinetic control of oxygenated apatites: Dynamic operation of a pilot-scale precipitation reactor for bone-mimetic biomaterials. Minerals.

Bennari, H., Belouafa, S., & Chaair, H. (2025, June 1). The economic and agricultural significance of Phoenix dactylifera: Challenges and opportunities for sustainable development in Morocco’s date palm sector. Journal of Food Science and Technology (Iran).

Bennari, H., El Omari, S., Habsaoui, A., Chaair, H., & Belouafa, S. (2025, February). Toward ISO/IEC 17025 compliance: Challenges and strategies for a university research laboratory. Accreditation and Quality Assurance.

Amer Hayat | Pharmacology | Best Researcher Award

Published on by Life Science

Dr. Amer Hayat | Pharmacology | Best Researcher Award

Universiti Sains Malaysia | Malaysia

Dr. Amer Hayat Khan, currently serving as a Senior Lecturer at the School of Pharmaceutical Sciences, Universiti Sains Malaysia, is an accomplished researcher with an outstanding academic and scientific profile. According to his Google Scholar and Scopus research metrics, Dr. Khan has authored over 240 scientific documents, contributing significantly to areas such as infectious diseases, antibiotic stewardship, nephrology, tuberculosis management, and clinical pharmacy practice. His research excellence is reflected in his h-index of 28 and a total of more than 2638citations, demonstrating his global scholarly influence and consistent impact across multidisciplinary pharmaceutical and biomedical fields. Dr. Khan’s publications appear in prestigious journals, including Frontiers in Pharmacology, BMC Infectious Diseases, PLoS ONE, and Expert Review of Anti-Infective Therapy, emphasizing his commitment to advancing patient-centered clinical research. His work integrates translational outcomes and evidence-based healthcare innovation, shaping regional and international research collaborations. Dr. Amer Hayat Khan’s profile embodies research leadership and mentorship excellence, making him a valuable contributor to global scientific progress.

Featured Publications

Abubakar, U., Subramaniam, L., & Khan, A. H. (2025). Knowledge, attitude, perception, and self-reported confidence of community pharmacists towards pharmacogenomics services. Journal of Pharmaceutical Policy and Practice.

Said, M. S., Fatima, R., Ahmad, R., Al Rawi, M. B. A., Jan, F., Faisal, S., Khan, I., & Khan, A. H. (2025). Evaluation of social and clinical factors associated with adverse drug reactions among children with drug-resistant tuberculosis in Pakistan. Tropical Medicine and Infectious Disease, 10(7), 176.

 Said, M. S., Fatima, R., Ooi, G. S., Khan, A., Al-Rawi, M. B. A., Khan, I., & Khan, A. H. (2025). Incidence, management and factors affecting unsuccessful treatment outcomes in pediatric multidrug-resistant tuberculosis patients: A cross-sectional retrospective study in Pakistan. Infectious Microbes and Diseases, 5(2), e182.

 Al-Rawi, M., Khan, A., & Sheikh Ghadzi, S. M. (2025). The severity of COVID-19 among chronic disease patients in the selected hospitals in Riyadh, Saudi Arabia – A retrospective study [Corrigendum]. Risk Management and Healthcare Policy, 18, 85–87.

Mustafa, Z. U., Khan, A. H., Salman, M., Harun, S. N., Meyer, J. C., & Godman, B. (2024). Assessment of rational antibiotic use among children being treated in primary care facilities in Punjab, Pakistan: Findings and implications. Drugs & Therapy Perspectives, 40(1), 23–30